<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-I422YZ1G</identifier><date>2025</date><creator>Karas Kuželički, Nataša</creator><relation>documents/doc/I/URN_NBN_SI_doc-I422YZ1G_001.pdf</relation><relation>documents/doc/I/URN_NBN_SI_doc-I422YZ1G_001.txt</relation><format format_type="issue">1</format><format format_type="volume">76</format><format format_type="type">article</format><format format_type="extent">str. 58-59</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">230994179</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-I422YZ1G</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>BY-NC</rights><subject language_type_id="slv">Zdravila</subject><title>Ameriški urad za zdravila in prehrano je odobril nov neopiodni analgetik</title><title>novice iz sveta farmacije</title></Record>